LEARSID BIOMEDI Corporate Presentation November 2022 : | --- | --- | |-------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------| | Forward-Looking Statements | | | This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of | 1995, as amended. | Developing and Delivering Treatments that Restore and Preserve Vision for Serious Back of the Eye ...

LEARSID BIOMEDI Corporate Presentation November 2022 : | --- | --- | |-------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------| | Forward-Looking Statements | | | This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of | 1995, as amended. | Developing and Delivering Treatments that Restore and Preserve Vision for Serious Back of the Eye ...

Clearside Biomedical, Inc. (NASDAQ:CLSD) Q3 2022 Earnings Call Transcript November 9, 2022 8:30 AM ET Company Representatives George Lasezkay - Chief Executive Officer Tom Ciulla - Chief Medical Officer, Chief Development Officer Charles Deignan - Chief Financial Officer Dr. Arshad Khanani - Managing Partner at Sierra Eye Associates, Clinical Associate Professor at the University of Nevada Jenny Kobin - Investor Relations Conference Call Participants Andreas Argyrides - Wedbush Annabel Samimy - Stifel John ...

LEARSI BIOMEDI Corporate Presentation August 2022 . Forward-Looking Statements This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. The words "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "project," "potential," "continue," "target" and similar expressions are intended to identify forward-looking statements, although not all forwardlooking statements conta ...

Clearside Biomedical Inc (NASDAQ:CLSD) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Jenny Kobin - Head of IR George Lasezkay - President, CEO and Director Tom Ciulla - Chief Medical Officer and Chief Development Officer Charles Deignan - CFO Conference Call Participants Stacy Lee - Stifel Rohit Bhasin - Needham & Company Yi Chen - H.C. Wainwright William Wood - B. Riley Operator Good day, and thank you for standing by. Welcome to the Clearside Biomedical Q2 2022 Financial ...

Clearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Jenny Kobin - Investor Relations George Lasezkay - President and Chief Executive Officer Thomas Ciulla - Chief Medical Officer and Chief Development Officer Charles Deignan - Chief Financial Officer Conference Call Participants Zegbeh Jallah - ROTH Capital Partners Jonathan Wolleben - JMP Securities Yi Chen - H.C. Wainwright Serge Belanger - Needham Julian Harrison - BTIG Operator Good day ...

LEARSI BIOMED Corporate Presentation March 2022 t 12222 Forward-Looking Statements This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. The words "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "project," "potential," "continue," "target" and similar expressions are intended to identify forward-looking statements, although not all forwardlooking statements c ...

Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2021 Results Conference Call March 10, 2022 4:30 PM ET Company Participants Jenny Kobin - Investor Relations George Lasezkay - Chief Executive Officer Dr. Thomas Ciulla - Chief Medical Officer and Chief Development Officer Charlie Deignan - Chief Financial Officer Conference Call Participants Annabel Samimy - Stifel Andreas Argyrides - Wedbush Zegbeh Jallah - ROTH Capital Partners Rohit Basin - Needham Jon Wolleben - JMP Securities Operator Good day. Thank you for ...

Clearside Biomedical, Inc. (NASDAQ:CLSD) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Jenny Kobin - Investor Relations George Lasezkay - Chief Executive Officer Thomas Ciulla - Chief Medical Officer and Chief Development Officer Charlie Deignan - Chief Financial Officer Conference Call Participants Annabel Samimy - Stifel Yi Chen - H.C. Wainwright Andreas Argyrides - Wedbush Jon Wolleben - JMP Securities Zegbeh Jallah - ROTH Capital Partners Operator Good day. Thank you ...

Clearside Biomedical, Inc. (NASDAQ:CLSD) Q2 2021 Earnings Conference Call August 10, 2021 4:30 PM ET Company Participants Jenny Kobin - Investor Relations George Lasezkay - Chief Executive Officer Thomas Ciulla - Chief Medical Officer and Chief Development Officer Charlie Deignan - Chief Financial Officer Conference Call Participants Zegbeh Jallah - ROTH Capital Partners Annabel Samimy - Stifel Andreas Argyrides - Wedbush Securities Yi Chen - H.C. Wainwright Jon Wolleben - JMP Securities Serge Belanger - Ne ...